<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Abo_blood_groups</id>
	<title>Abo blood groups - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Abo_blood_groups"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Abo_blood_groups&amp;action=history"/>
	<updated>2026-04-17T03:24:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Abo_blood_groups&amp;diff=4968444&amp;oldid=prev</id>
		<title>Prab at 13:25, 17 September 2023</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Abo_blood_groups&amp;diff=4968444&amp;oldid=prev"/>
		<updated>2023-09-17T13:25:02Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The &amp;#039;&amp;#039;&amp;#039;ABO blood grouping system&amp;#039;&amp;#039;&amp;#039; is a fundamental classification of human blood types, determined by the presence or absence of specific antigens on red blood cells and antibodies in the plasma. These antigens and antibodies dictate a person&amp;#039;s blood type and compatibility for blood transfusion. The ABO system is universally recognized as the most significant system for blood transfusion compatibility.&lt;br /&gt;
[[File:ABO blood type.svg|thumb|right|410px|ABO blood group [[antigen]]s present on [[red blood cell]]s and [[IgM]] [[antibodies]] present in the [[Blood serum|serum]]]]&lt;br /&gt;
===Understanding Blood Groups===&lt;br /&gt;
&lt;br /&gt;
The ABO blood grouping divides blood into four main types, determined by the presence or absence of two main antigens and antibodies. The categorization is as follows:&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! ABO Group !! Blood Type !! Antigen A !! Antigen B !! Anti A antibody !! Anti B antibody&lt;br /&gt;
|-&lt;br /&gt;
| A || yes || no || no || yes&lt;br /&gt;
|-&lt;br /&gt;
| B || no || yes || yes || no&lt;br /&gt;
|-&lt;br /&gt;
| O || no || no || yes || yes&lt;br /&gt;
|-&lt;br /&gt;
| AB || yes || yes || no || no&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
For instance, an individual with the A blood type has A antigens and anti-B antibodies. This system ensures safe blood transfusions, as the recipient&amp;#039;s immune system could attack incompatible blood.&lt;br /&gt;
&lt;br /&gt;
==Blood Donation Screening==&lt;br /&gt;
&lt;br /&gt;
Ensuring the safety of both blood donors and recipients is paramount. Screening procedures are in place to minimize the risk of transfusing infectious diseases.&lt;br /&gt;
&lt;br /&gt;
===Donor Evaluation===&lt;br /&gt;
&lt;br /&gt;
Before donation, potential donors undergo a questionnaire to assess their eligibility. Those at risk of carrying transmittable diseases or who are unwell are deferred.&lt;br /&gt;
&lt;br /&gt;
===Testing Donated Blood===&lt;br /&gt;
&lt;br /&gt;
After donation, the blood undergoes multiple tests:&lt;br /&gt;
&lt;br /&gt;
* Blood typing (ABO group)&lt;br /&gt;
* Rh typing (positive or negative)&lt;br /&gt;
* Screening for infectious pathogens&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! Infectious Disease Pathogen !! Laboratory Tests Used&lt;br /&gt;
|-&lt;br /&gt;
| Bacterial Contamination || Bacterial culture&lt;br /&gt;
|-&lt;br /&gt;
| Hepatitis B virus (HBV) || Hepatitis B surface antigen (HBsAg) detection&amp;lt;br&amp;gt;Hepatitis B core antibody (anti-HBc) detection&lt;br /&gt;
|-&lt;br /&gt;
| Hepatitis C virus (HCV) || Hepatitis C virus antibody (anti-HCV) detection&amp;lt;br&amp;gt;Nucleic acid amplification testing (NAT) for HCV&lt;br /&gt;
|-&lt;br /&gt;
| Human Immunodeficiency virus Types 1 and 2 (HIV) || HIV-1 and HIV-2 antibody (anti-HIV-1 and anti-HIV-2) detection&amp;lt;br&amp;gt;Nucleic acid amplification testing (NAT) for HIV-1&lt;br /&gt;
|-&lt;br /&gt;
| Human T-Lymphotropic Virus Types I and II (HTLV) || HTLV-I and HTLV-II antibody (anti-HTLV-I and anti-HTLV-II) detection&lt;br /&gt;
|-&lt;br /&gt;
| Treponema pallidum (syphilis) || Anti-treponemal antibody detection&lt;br /&gt;
|-&lt;br /&gt;
| West Nile virus (WNV) || Nucleic acid amplification testing (NAT) for WNV&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions to Blood Transfusions==&lt;br /&gt;
&lt;br /&gt;
While the risk of an adverse reaction during a blood transfusion is low, it&amp;#039;s vital to understand potential complications. Reactions can range from mild allergic responses to severe and life-threatening conditions.&lt;br /&gt;
&lt;br /&gt;
===Common Reactions===&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Allergic reaction to blood transfusion&amp;#039;&amp;#039;&amp;#039;: Caused by a clash between the transfused allergen and the recipient&amp;#039;s pre-existing antibodies.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Acute hemolytic transfusion reaction (AHTR)&amp;#039;&amp;#039;&amp;#039;: Rapid destruction of red blood cells due to receiving an incompatible blood type.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Delayed hemolytic transfusion reaction (DHTR)&amp;#039;&amp;#039;&amp;#039;: The body develops antibodies against transfused red blood cell antigens after 24 hours to 28 days post-transfusion.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Delayed serologic transfusion reaction (DSTR)&amp;#039;&amp;#039;&amp;#039;: New antibodies against red blood cells develop within 24 hours to 28 days post-transfusion without clinical symptoms.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Febrile non-hemolytic transfusion reaction (FNHTR)&amp;#039;&amp;#039;&amp;#039;: Characterized by fever and/or chills without the breakdown of red blood cells.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Hypotensive transfusion reaction&amp;#039;&amp;#039;&amp;#039;: A drop in blood pressure immediately after starting the transfusion.&lt;br /&gt;
&lt;br /&gt;
===Rare Reactions===&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;[[Post-transfusion purpura]] (PTP)&amp;#039;&amp;#039;&amp;#039;: Rapid destruction of platelets, leading to a sharp decrease in platelet count.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;[[Transfusion-associated circulatory overload]] (TACO)&amp;#039;&amp;#039;&amp;#039;: Fluid overload in the recipient&amp;#039;s circulatory system.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;[[Transfusion-related acute lung injury]] (TRALI)&amp;#039;&amp;#039;&amp;#039;: Fluid accumulation in the lungs.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;[[Transfusion-associated dyspnea]] (TAD)&amp;#039;&amp;#039;&amp;#039;: Respiratory distress post-transfusion.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;[[Transfusion-associated graft vs. host disease]] (TAGVHD)&amp;#039;&amp;#039;&amp;#039;: Donor T-lymphocytes attack the recipient&amp;#039;s cells, causing symptoms such as fever and rash.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;[[Transfusion-transmitted infection]] (TTI)&amp;#039;&amp;#039;&amp;#039;: Introduction of a pathogen through transfused blood.&lt;br /&gt;
{{stub}}&lt;br /&gt;
{{Transfusion medicine}}&lt;br /&gt;
[[Category:Blood antigen systems]]&lt;br /&gt;
[[Category:Transfusion medicine]]&lt;br /&gt;
[[Category:Antigenic determinant]]&lt;br /&gt;
[[Category:Hematopathology]]&lt;br /&gt;
[[Category:Glycoproteins]]&lt;br /&gt;
[[Category:Serology]]&lt;br /&gt;
[[Category:Genes on human chromosome 9]]&lt;br /&gt;
[[Category:Health and Medicine]]&lt;br /&gt;
[[Category:health]]&lt;br /&gt;
[[Category:hematology]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>